Every woman with Hashimoto's who sits across from me describes the same appointment.
The bloodwork comes back. The doctor smiles. "Your TSH is normal."
And her hair keeps falling out anyway.
From the thousands of women I've consulted with at the Reisman Scalp & Follicle Institute over the past four years, the shedding almost always comes down to the same mistake — they're treating a problem that isn't happening where they think it's happening.
Some are at the very beginning — months after diagnosis, the first handful in the shower, still telling themselves the medication needs time. Some are years in — ponytail half what it was, part widened, every lab "optimized," brush unrecognizable.
What starts as "a little more shedding than usual" becomes a thinner ponytail by the first dose change. A widening part by the second. Visible scalp while every test says "normal."
Most of them tell me they've already been given the verdict. Hair loss is "just part of managing Hashimoto's." Something to accept. The ones who haven't accepted it yet are stockpiling biotin, optimizing ferritin, adding selenium, going gluten-free, and pouring expensive masks onto strands that are already dead. None of it is changing the count. If anything, the supplements are making them feel worse — bloated, nauseous, no closer to keeping the hair.
After watching dozens of women come through with this exact pattern — and after a 2024 study from the University of Illinois Chicago made the mechanism clinically undeniable — last year my team commissioned an independent 6-week clinical study to find out what was actually happening at the follicle, and whether a topical protocol could reverse it.
It was the first study of its kind. We measured every shed strand — by hand. From the brush. From the wash. Before and after. The trial enrolled women between 40 and 60 with diagnosed Hashimoto's, on stable thyroid medication, with normal TSH — and documented shedding.
The exact situation their doctors keep telling them is fine.
Here's what we found.
Hair lost in the brush dropped by 62%.
Hair lost in the wash dropped by 71%.
With 94% of the women seeing their shedding return to a normal baseline within the first six weeks.
The trial was peer-reviewed and accepted by the Journal of Drugs in Dermatology for publication in their June 2026 issue.
And the technique those women used in the trial is straightforward once you know what your hair actually needs — which has nothing to do with your TSH, your dose, or another blood panel.